Last updated: July 3, 2024
Sponsor: University Hospital Tuebingen
Overall Status: Completed
Phase
N/A
Condition
Cervical Intraepithelial Neoplasia
Neoplasms
Genitourinary Cancer
Treatment
Non-invasive physical plasma
Clinical Study ID
NCT04753073
ZGynO_CIN_III
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 18 years
Histologically confirmed CIN III
Clearly visible transformation zone of the portio and margins of the lesionsaccording to T1 / T2
signed written consent
Exclusion
Exclusion Criteria:
Not fully visible transformation zone
Indication of an invasive disease
Serious cardiovascular diseases
Patients who only want to undergo a LEEP excision
Study Design
Total Participants: 38
Treatment Group(s): 1
Primary Treatment: Non-invasive physical plasma
Phase:
Study Start date:
February 01, 2021
Estimated Completion Date:
June 30, 2024
Study Description
Connect with a study center
University Hospital Tuebingen, Department of Women's Health
Tuebingen, 72076
GermanySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.